Low rates of major adverse cardiac events, malignancies, and serious infections in subjects with psoriasis and psoriatic arthritis treated with apremilast for = 156 weeks: pooled analysis from the ESTEEM and PALACE 1-3 phase 3 trials

著录项

• 来源
  《Scandinavian journal of rheumatology》 |2018年第129期|共2页
• 作者

  Kavanaugh A.; Augustin M.; Lespessailles E.; Papp K.; Paris M.; Gladman D.; Pariser D.; Peris K.;

  展开▼
• 作者单位

  Univ Calif La Jolla San Diego Sch Med Div Rheumatol Allergy &

  Immunol La Jolla CA USA;

  Univ Med Ctr Hamburg Eppendorf UKE Inst Hlth Serv Res Dermatol &

  Nursing IVDP Hamburg Germany;

  Univ Orleans Rheumatol Dept Orleans France;

  Clin Res &

  Prob Med Res Waterloo ON Canada;

  Celgene Corp Summit NJ USA;

  Toronto Western Hosp Krembil Res Inst Toronto ON Canada;

  Eastern Virginia Med Sch Dept Dermatol Norfolk VA 23501 USA;

  Univ Cattolica Sacro Cuore Dept Dermatol Rome Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 免疫性疾病;
• 关键词